Testing for Mycoplasma
illumigene® Mycoplasma Direct
illumigene® is the only molecular platform that offers standalone
assays for the detection of Mycoplasma pneumoniae. M. pneumoniae has been associated with up to 40% of
community-acquired pneumonias. Accurate diagnosis of Mycoplasma pneumonia is critical to provide appropriate
antibiotic therapy. illumigene® Mycoplasma Direct detects Mycoplasma pneumonia in throat swab specimens.
illumigene® Mycoplasma Direct is ideal for enabling a more rapid diagnosis, providing earlier identification of outbreaks and prevention of secondary cases through implementation of control measures.
ImmunoCard® Mycoplasma tests for the presence
of IgM antibody to Mycoplasma pneumoniae in human serum using enzyme immunoassay
(EIA) technology. The presence of IgM indicates early/acute disease. The presence
of IgG (alone or with IgM) is associated with convalescent disease or previous exposure
to Mycoplasma with subclinical infection.
Mycoplasma methodology provides a simple-to-use, self-contained device. No calculations
are required and the visual color change makes interpretation of results objective
Learn more about treatment for Mycoplasma infection